ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,075.30
      0.23%
      US Tech 100
      21,088.40
      0.07%
      Dow Jones
      44,793.37
      -0.18%
      Brent Oil
      74.685
      0.14%
      Bitcoin
      97,524.69
      0.94%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Ironwood Pharmaceuticals Inc (IRWD) Quote

      Ironwood Pharmaceuticals Inc

      Ironwood Pharmaceuticals Inc (IRWD)

      NASDAQ
      1.9288
      -0.1812
      ( -8.59% )
      Updated: 11:00:17
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.9288
      Bid
      1.92
      Ask
      1.93
      Volume
      2,900,700
      1.8909 Day's Range 2.14
      1.8909 52 Week Range 15.70
      Market Cap
      308.663M
      Previous Close
      2.11
      Open
      2.14
      Last Trade
      10
      @
      1.925
      Last Trade Time
      11:00:24
      Financial Volume
      $ 6,029,396
      VWAP
      2.0786
      Average Volume (3m)
      2,282,753
      Shares Outstanding
      160,028,388
      Dividend Yield
      -
      PE Ratio
      -0.31
      Earnings Per Share (EPS)
      -6.26
      Revenue
      442.74M
      Net Profit
      -1B

      About Ironwood Pharmaceuticals Inc

      Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ironwoodpharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Ironwood Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IRWD. The last closing price for Ironwood Pharmaceuticals was $2.11. Over the last year, Ironwood Pharmaceuticals shares have traded in a share price range of $ 1.8909 to $ 15.70.

      Ironwood Pharmaceuticals currently has 160,028,388 shares outstanding. The market capitalization of Ironwood Pharmaceuticals is $337.66 million. Ironwood Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.31.

      Ask ADVFN Intelligence (AI)

      IRWD Latest News

      More News

      Millrose Properties Set to Join S&P SmallCap 600

      Millrose Properties Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 5, 2025 NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Millrose Properties Inc. (NYSE: MRP) will replace Ironwood...

      17 hours ago
      PR Newswire (US)

      FeaturedVAYK Project $700K 2024 Revenue with $150K Net Profit

      23 hours ago

      Form 4 - Statement of changes in beneficial ownership of securities

      January 29 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 29 2025
      Edgar (US Regulatory)

      Form 3 - Initial statement of beneficial ownership of securities

      January 29 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 29 2025
      Edgar (US Regulatory)

      Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

      – Data from open label extension study of apraglutide demonstrate further increase in patients achieving enteral autonomy – – Initiated rolling NDA submission, now to include long-term extension...

      January 29 2025
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      January 22 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 22 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 22 2025
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.3712-41.55151515153.33.41.890946293522.24075371CS
      4-2.7062-58.38619201734.6354.6351.890923887912.89541656CS
      12-2.3712-55.14418604654.35.12881.890922827533.60667019CS
      26-4.2912-68.99035369776.226.281.890920294294.02755146CS
      52-12.8212-86.923389830514.7515.71.890927302096.97296115CS
      156-9.1312-82.560578661811.0615.71.890925416189.59397067CS
      260-10.6012-84.606544293712.5315.71.8909230928710.11022408CS

      IRWD - Frequently Asked Questions (FAQ)

      What is the current Ironwood Pharmaceuticals share price?
      The current share price of Ironwood Pharmaceuticals is $ 1.9288
      How many Ironwood Pharmaceuticals shares are in issue?
      Ironwood Pharmaceuticals has 160,028,388 shares in issue
      What is the market cap of Ironwood Pharmaceuticals?
      The market capitalisation of Ironwood Pharmaceuticals is USD 337.66M
      What is the 1 year trading range for Ironwood Pharmaceuticals share price?
      Ironwood Pharmaceuticals has traded in the range of $ 1.8909 to $ 15.70 during the past year
      What is the PE ratio of Ironwood Pharmaceuticals?
      The price to earnings ratio of Ironwood Pharmaceuticals is -0.31
      What is the cash to sales ratio of Ironwood Pharmaceuticals?
      The cash to sales ratio of Ironwood Pharmaceuticals is 0.7
      What is the reporting currency for Ironwood Pharmaceuticals?
      Ironwood Pharmaceuticals reports financial results in USD
      What is the latest annual turnover for Ironwood Pharmaceuticals?
      The latest annual turnover of Ironwood Pharmaceuticals is USD 442.74M
      What is the latest annual profit for Ironwood Pharmaceuticals?
      The latest annual profit of Ironwood Pharmaceuticals is USD -1B
      What is the registered address of Ironwood Pharmaceuticals?
      The registered address for Ironwood Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Ironwood Pharmaceuticals website address?
      The website address for Ironwood Pharmaceuticals is www.ironwoodpharma.com
      Which industry sector does Ironwood Pharmaceuticals operate in?
      Ironwood Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LTRYLottery com Inc
      $ 1.1293
      (130.52%)
      		109.46M
      APPSDigital Turbine Inc
      $ 4.6888
      (84.60%)
      		59.68M
      LIPOLipella Pharmaceuticals Inc
      $ 4.75
      (84.11%)
      		67.91M
      INVZWInnoviz Technologies Ltd
      $ 0.1496
      (65.12%)
      		122.5k
      QNTMQuantum Biopharma Ltd
      $ 13.43
      (56.53%)
      		16.4M
      RETOReTo Eco Solutions Inc
      $ 0.5198
      (-35.03%)
      		524.39k
      SDASunCar Technology Group Inc
      $ 5.8099
      (-31.16%)
      		1.92M
      LYTLytus Technologies Holdings PTV Ltd
      $ 0.2904
      (-30.36%)
      		1.22M
      SRTSSensus Healthcare Inc
      $ 6.315
      (-29.76%)
      		1.4M
      AVGRAvinger Inc
      $ 0.3977
      (-28.97%)
      		874.08k
      LTRYLottery com Inc
      $ 1.1293
      (130.52%)
      		109.46M
      CYNCYNGN Inc
      $ 0.0811
      (-1.10%)
      		88.62M
      NVDANVIDIA Corporation
      $ 126.55
      (1.38%)
      		85.98M
      RIMEAlgorhythm Holdings Inc
      $ 0.021389
      (2.34%)
      		77.77M
      MGOLMGO Global Inc
      $ 0.170399
      (22.59%)
      		68.51M

      IRWD Discussion

      View Posts
      ProLiberty ProLiberty 6 months ago
      Possible buy below $5? Any chance the VectivBio acquisition ends up not being as horrible as it currently appears? When might the acquired asset begin to generate revenue?
      👍️0
      Monksdream Monksdream 10 months ago
      IRWD under $10
      👍️0
      philaya philaya 11 months ago
      sold...
      fast trading.
      👍️0
      philaya philaya 11 months ago
      Using radar...
      Got this today
      👍️0
      Dubster watching Dubster watching 11 months ago
      B$9.01
      👍️0
      BabySealHugger BabySealHugger 4 years ago
      Hearing rumblings of IRWD this week. Anyone else?
      👍️0
      whytestocks whytestocks 4 years ago
      Just In: $IRWD Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Transcript

      Image source: The Motley Fool. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q3 2020 Earnings Call Nov 6, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Trans...

      Find out more IRWD - Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Transcript
      👍️0
      whytestocks whytestocks 4 years ago
      Just In: $IRWD Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment

      – Trial did not achieve statistically significant improvement in heartburn severity (primary endpoint) – – Ironwood plans to implement organizational restructuring, resulting in expected headcount reduction of approximately 100 full-time employees, or near...

      In case you are interested IRWD - Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment
      👍️0
      whytestocks whytestocks 6 years ago
      News: $IRWD Ironwood and Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

      – Phase IIIb study met all primary and secondary endpoints with statistical significance and demonstrated that linaclotide improved the overall abdominal symptoms of bloating, pain and discomfort in adults with IBS-C – – Results further support the efficacy and s...

      Got this from https://marketwirenews.com/news-releases/ironwood-and-allergan-report-positive-topline-data-from-phase-iiib-trial-of-linzess-xae-linaclotide-in-adults-with-irritable-bowel-syndrome-with-constipation-ibs-c--8377600.html
      👍️0
      ClayTrader ClayTrader 6 years ago
      * * $IRWD Video Chart 05-17-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      stocktrademan stocktrademan 6 years ago
      IRWD buy 11.365

      https://www.ironwoodpharma.com/



      normal chart







      log chart






      👍️0
      chemist99 chemist99 6 years ago
      epilogue

      SGYP down to 3 pennies after hours today

      the signs were all there, but you had to be willing to read them.

      if there is a list somewhere, like, "always go on the opposite end of the trade for all recommendations from these institutions" - most of the SGYP institutional investors should definitely be on it IMHO.
      👍️0
      chemist99 chemist99 6 years ago
      How did that work out for you;)
      👍️0
      chemist99 chemist99 7 years ago
      knew all too well what was going on behind the Synergy scenes;

      http://www.nj.com/business/index.ssf/2012/08/bristol-myers_drug_flop_erases.html


      if you make a multinational company lose a couple billion $ in short order & leave them stuck with trial deaths, AND expect anyone in the pharmaceutical industry ever to trust you again, you need to have your head examined imo. he's probably looking under his car every morning...

      there's a really nice package deal available for you though from the experienced crew, if you're still game for it:

      Synergy, $6 in January, now on sale at $1.90, Trovagene, went public at $24, now marked down to 51 cents for quick clearance, and ContraVir, $5 as recently as 2015, but now available for just 49 cents! Yes, you get all three of these made-to-be-sold companies for just $2.90! And, if you act now, we'll throw in 10 shares of Callisto Pharmaceuticals, a company which sank beneath the waves with Cap'n Gary at the helm!

      👍️0
      chemist99 chemist99 7 years ago
      Enjoy the front row seat to the final act of the drama, sure was expensive enough...
      👍️0
      chemist99 chemist99 7 years ago
      Q.e.d.
      👍️0
      Inoviorulez Inoviorulez 8 years ago
      https://seekingalpha.com/article/4089539-ironwood-will-press-good-fight-gerd
      👍️0
      chemist99 chemist99 8 years ago
      :(
      👍️0
      chemist99 chemist99 8 years ago
      :)
      👍️0
      chemist99 chemist99 9 years ago
      Brilliant !
      👍️0
      brownsfan407 brownsfan407 9 years ago
      I did 10,000 shares on that one, didn't get in at the low, but out close to the top. Flipped it into sgyp in the low 3's
      👍️0
      chemist99 chemist99 9 years ago
      thanks for bringing it to my attention! that was nice, ~7.30s to $10.24 in less than a month, 30+% !
      Hope you didn't miss it :) ?
      👍️0
      brownsfan407 brownsfan407 9 years ago
      you were right, we saw 7's this week. 52 week low
      👍️0
      chemist99 chemist99 10 years ago
      SGYP short volume 25 million plus now...looks like the hedgefunds are in the business to lose money then ?
      👍️0
      brownsfan407 brownsfan407 10 years ago
      under 10 coming your way soon. the trend is your friend
      👍️0
      brownsfan407 brownsfan407 10 years ago
      IRWD, 10.71 new 52 week low fact, not rant
      8.00 in September lows
      👍️0
      chemist99 chemist99 10 years ago
      no pain data, skewed side effect profile = no partner IMO.

      no partner = slim chance, if any, of competing in the marketplace for a primary care drug with an army of people promoting the first-to-market competitor, IMO.

      simple as that.

      rant all you want. doesn't change the fact that Phase III CIC data are out - and still no buyout & no partnership despite the "hey we're for sale" press article LOL.

      that, and the low (~30%) institutional ownership of SGYP compared with IRWD (~100%), combined with the ~22 mill. short volume for SGYP speak volumes...



      👍️0
      brownsfan407 brownsfan407 10 years ago
      IRWD pennies of 51 week low, while market booms. Stock price heading in the same direction as the diarrhea it causes. despite misinformation by IRWD propagandist.. BTW, I bought a boatload of warrants at .36, now 4.00. I can be very patient for the next explosion. 2 phase 3 results and an NDA by year end
      👍️0
      brownsfan407 brownsfan407 10 years ago
      from an IRWD board? nice, just a little biased. Don't try to be naïve, you have no idea what is going on behind the scenes. and like I said you have lots of holders, but yahoo stats says 3 percent own over 5 percent, and that 3 percent includes insider holdings. Everyone owns a little. Cerrone TOOK 1/2 year with inhibitex, to get top buck, we have only been a month here. 4 catalysts by year end. we are up 165 percent, you? your short at 4 dollars is a FAILED trade
      👍️0
      chemist99 chemist99 10 years ago
      sooner or later the Wall Street hysteria, fanned by a couple of hyperbolic analyst op ed pieces, will be over; - the music will stop, people will wake up & valuations will adjust to reality. they always do.

      I quote a comment of someone from "the trenches" posted on the IRWD CP board, who puts it in quite simple (& blunt) terms:

      anonymous, Jul 22, 2015 at 9:37 AM
      (quote) ...." Less diarrhea, yes but with that is less efficacy. You can't treat cic with no diarrhea and have the same efficacy. So you think you can hire a third of the reps ? So roughly 1 rep per state to grow the constipation market of 50 million? This is a primary care drug linzess has over 3000 people promoting it. When it is all said and done 80 percent of volume will come from pcp. You need a partner and despite your so called stellar efficacy and no side effects no one is stepping up. No pain data and skewed side effect data equals no partner. We developed plecanatide and linaclotide and kept linzess. I'm gonna go with the MIT scientists who discovered GCC on this one..."

      http://www.cafepharma.com/boards/threads/we-should-buy-synergy.583049/

      👍️0
      brownsfan407 brownsfan407 10 years ago
      I don't know the answer, but do you think they are happy with the price DEpreciation, under 11, it has been YEARS since it has been that low
      👍️0
      chemist99 chemist99 10 years ago
      IRWD:
      % of Shares Held by Institutional & Mutual Fund Owners: 110%
      % of Float Held by Institutional & Mutual Fund Owners: 112%
      Number of Institutions Holding Shares: 163

      SGYP:
      % of Shares Held by Institutional & Mutual Fund Owners: 29%
      % of Float Held by Institutional & Mutual Fund Owners: 32%
      Number of Institutions Holding Shares: 90

      source: Yahoo finance 07/22/15
      👍️0
      brownsfan407 brownsfan407 10 years ago
      % of Shares Held by All Insider and 5% Owners: 2 percent. surprisingly low. lots with their toes in the water, but no ringing endorsements
      👍️0
      brownsfan407 brownsfan407 10 years ago
      I can explain the price drop in facts, but I can't help you to understand it
      👍️0
      brownsfan407 brownsfan407 10 years ago
      Chemist, you the only one here? Looks like it
      👍️0
      brownsfan407 brownsfan407 10 years ago
      but our price is going up, I am sorry, which way is this price going? It is not going to be long before our price eclipses yours
      👍️0
      chemist99 chemist99 10 years ago
      Sgyp new short volume ~ 22 mill; - go figure ??
      👍️0
      brownsfan407 brownsfan407 10 years ago
      chemist, short up to 17 mill, too bad you can't use your moniker to reformulate this drug into something better, but then again, what chemistry do you need to use a virus?
      👍️0
      brownsfan407 brownsfan407 10 years ago
      hot 6 page found in nature thing working for you? I am having trouble with my pixels, did wedbush lower the target to 11? that's lower than the current price
      👍️0
      brownsfan407 brownsfan407 10 years ago
      6/15 was days before the phase 3 results. I bet some more shorted the 9 down to 8 to cover the earlier bad trade. We hire 2 more big guns today, and the pump articles and increasing price targets are like ants around a popsicle on a picnic, they are everywhere. Synergy will do ma secondary at 13, pay back the loan, and actually lower their share count, and knock off the interest
      👍️0
      chemist99 chemist99 10 years ago
      yes, IRWD short interest up to ~16 million shares, but SGYP up even more to about ~21.5 million shares per 06/15 :
      http://www.nasdaq.com/symbol/sgyp/short-interest

      the hedge funds must be in the business to lose money, I guess...
      👍️0
      brownsfan407 brownsfan407 10 years ago
      Chemist, Last SI up 2 million, are there folks betting on this going down. are you hedged? Sgyp set to double
      👍️0
      brownsfan407 brownsfan407 10 years ago
      How about your long position here? 1/3 the diarrhea rate for plecanatide, and filing NDA in November. Has to severely stunt the growth here. What is the adage, the market is forward looking? However, maybe you can clarify. The guy who took IRWD through the NDA process, does he still work for you?
      👍️0
      brownsfan407 brownsfan407 10 years ago
      In a few months the ticker symbol for Synergy may not exist, in a perfect world
      👍️0
      chemist99 chemist99 10 years ago
      No short no loss. Let's compare notes again in a few months. Enjoy it while it lasts??
      👍️0
      brownsfan407 brownsfan407 10 years ago
      what did you lose on the short? 6 bucks per share? and now, your long shares here are severely compromised. I would have some compassion for you if it were not for your past smugness and haughtiness
      👍️0
      brownsfan407 brownsfan407 10 years ago
      Game, set, match, plecanatide is clearly better. Cannot dispute the numbers, as the 600 rode the 89 percent gain
      👍️0
      chemist99 chemist99 10 years ago
      oh well, it served it's purpose, I suppose :)
      👍️0
      brownsfan407 brownsfan407 10 years ago
      check out lpcn, oral trt, NDA BY Q3, pre-term birth PILL too. Low float monster
      👍️0
      chemist99 chemist99 10 years ago
      lol.

      a little knowledge can be a dangerous thing.
      👍️0

      Your Recent History

      NASDAQ
      IRWD
      Ironwood Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads